Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Breast 1

Conditions

Sarcoma 142 Osteosarcoma 26 Liposarcoma 25 Leiomyosarcoma 25 Histiocytoma, Malignant Fibrous 19 Hemangiosarcoma 18 Sarcoma, Synovial 17 Neurofibrosarcoma 17 Fibrosarcoma 17 Rhabdomyosarcoma 16 Dendritic Cell Sarcoma, Interdigitating 16 Sarcoma, Ewing 13 Neuroectodermal Tumors, Primitive, Peripheral 11 HIV Infections 11 Sarcoma, Kaposi 10 Neoplasms 10 Neoplasm Metastasis 10 Malignant mesenchymal tumor 10 Acquired Immunodeficiency Syndrome 10 Lymphoma, Large B-Cell, Diffuse 9 Dermatofibrosarcoma 9 Ovarian Neoplasms 8 Lymphoma 8 Hemangiopericytoma, Malignant 8 Desmoplastic Small Round Cell Tumor 8 Sarcoma, Alveolar Soft Part 6 Chondrosarcoma, Extraskeletal Myxoid 6 Bone Neoplasms 6 Chondrosarcoma 5 Burkitt Lymphoma 5

Interventions

Diathermy 3 Surgical Procedures, Operative 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Melphalan 1 Ifosfamide 1 Doxorubicin 1 Dacarbazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperthermia × Doxorubicin × Sarcoma × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡